Dall, P.(2017). Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany. The Oncologist, 22(2), 131-138. doi:10.1634/theoncologist.2016-0193
MLA CitationDall, Peter. "Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study On Routine Treatment Between 2006 and 2012 in Germany". The Oncologist, 22.2 ( 2017 ): 131-138.
Remember to check citations for accuracy before including them in your work.